Home / Research and experimental development on biotechnology (except medical and veterinary science)

EBVISION BIOTECHNOLOGY PTE. LTD.

Live CompanyUEN 202601232RLocal Company

EBVISION BIOTECHNOLOGY PTE. LTD. is a local company in Singapore with UEN 202601232R. It was registered on 8 Jan 2026. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202601232R
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered8 Jan 2026
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity72106 Research and experimental development on medical and veterinary sciences
Address8 RIVER VALLEY CLOSE, #10-05, THE AVENIR, Singapore 238432
14 companies at this address
AreaRiver Valley · District 9 (Orchard, Cairnhill, River Valley)
Nearest stationGreat World MRT, about 337 m
Officers4

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.